Catalyst Wire Dossier Catalyst Wire Dossier

Omlyclo®

omalizumab biosimilar · Celltrion HealthCare France
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Omlyclo®, covering 2025-11-18 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

See pricing